Trials / Sponsors / Thallion Pharmaceuticals
Thallion Pharmaceuticals
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2 Shiga Toxin Producing Bacterial Infection | Phase 2 | 2010-11-01 |
| Terminated | Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme Glioblastoma Multiforme | Phase 2 | 2008-08-01 |
| Terminated | Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma Melanoma | Phase 2 | 2008-08-01 |
| Completed | Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma Carcinoma, Renal Cell | Phase 2 | 2007-03-01 |
| Completed | A Phase I Study of ECO-4601 in Patients With Advanced Cancer Tumors, Glioma, Colorectal Cancer | Phase 1 | 2006-02-01 |